Shares of Glenmark Pharmaceuticals were lower on reports over the weekend that the company has lost a patent case against U.S. firm Abbott Laboratories over hypertension drug Tarka.
Subsequently,it will pay $16 million in damages to the U.S. firm,two dealers said.
At 9.25 a.m.,shares of the company were down 4.13 percent at 333.50 rupees.




